Medic8® Drug Information
"Medic8.com - Your trusted source for health information online"   Medic8
Family Health | Cosmetic Surgery | Medical Dictionary | Health Insurance | Search | About | Help  
HEALTH GUIDES
Cosmetic Surgery
Cosmetic Dentistry
Family Health
Health Insurance
Laser Eye Surgery
Life Insurance
Travel Health
MEDICAL A TO Z
Alternative Medicine
Blood Disorders
Cancer
Dental Disorders
Diabetes
Digestive Disorders
Ear & Hearing Disorders
Endocrine Disorders
Eye Disorders
Genetic Disorders
Heart Disorders
Infectious Diseases
Kidney Disorders
Lung Disorders
Mental Health
Neurological Disorders
Skin, Bone & Muscle Disorders
Sleep Disorders
TOPICS/THEMES
Allergies
Alternative Health
Arthritis
Asthma
Blood Disorders
Bones & Joints
Bowel & Abdominal Problems
Cancer
Chest Problems
Child Health
Circulation Problems
Cosmetic Surgery
Diabetes
Diet & Nutrition
Drug Addiction
Ear, Nose, & Throat Problems
Elderly Health
Eye Problems
Heart Problems
High Blood Pressure
Hormone & Endocrine Problems
Infections
Infertility
Liver Problems
Medications
Men's Health
Mental Health
Nervous System
Personal & Social Issues
Pregnancy & Birth
Preventive Health
Radiology
Sexual Health
Skin Problems
Sports Medicine
Surgery
Travel Health
Urinary & Kidney Problems
Vaccination
Women's Health
MISCELLANEOUS
Medic8 Search
Terms Of Use
About Medic8

Glibenclamide

Glibenclamide (INN), also known as glyburide (USAN), is an anti-diabetic drug in a class of medications known as sulfonylureas, used in the treatment of type II diabetes. The drug works by inhibiting ATP-sensitive potassium channels in pancreatic beta cells. This inhibition causes cell membrane depolarization, opening of voltage-dependent calcium channels, thus triggering an increase in intracellular calcium into the beta cell which stimulates insulin release. It is sold in doses of 1.25mg, 2.5mg and 5mg, under the trade names Diabeta®, Glynase® and Micronase® in the United States and Daonil®, Semi-Daonil® and Euglucon® in the United Kingdom.

It is also sold in combination with metformin under the trade name Glucovance®.

The drug is contraindicated in pregnant women. It is also a major cause of drug induced hypoglycaemia.

Recently published data suggests that glibenclamide is associated with significantly higher annual mortality when combined with metformin than other insulin secreting medications, after correcting for other potentially confounding patient characteristics. The safety of this combination has been questioned.


 

Source: wikipedia GFDL

Medic8® Medicines

Page last modified: May 2008


Online Guides


DISCLAIMER: This guide is provided for general information only and is not a substitute for professional medical advice. We are not responsible or liable for any diagnosis or action made by a user based on the content of this website. We are not liable for the contents of any external websites listed, nor do we endorse any commercial product or service mentioned or advised on any of the sites. Always consult your own doctor if you are in any way concerned about your health.

LEGAL CONDITIONS AND TERMS OF USE ARE APPLICABLE TO ALL USERS OF THIS GUIDE/WEBSITE. ANY USE OF THIS GUIDE CONSTITUTES YOUR AGREEMENT TO THESE TERMS OF USE. REPRODUCTION OF ANY PART OF THIS WEBSITE BY ANY MEANS, INCLUDING ELECTRONIC, IS EXPRESSLY PROHIBITED WITHOUT PRIOR WRITTEN CONSENT.

Medic8 logo
www.medic8.com

© Medic8®. All Rights Reserved.

- Medic8 - Health Guide - A to Z - Medical Dictionary - Terms Of Use - Privacy - About -